• CDIO’s vision reflects a broader shift taking place across the healthcare industry toward predictive and Precision Medicine.
• Achieving that goal requires a combination of scientific expertise, advanced technology, scalable testing and improved accessibility.
• Cardio Diagnostics’ focus on innovation is particularly relevant in cardiovascular disease, where earlier identification of risk factors can significantly influence outcomes.

Heart disease remains the leading cause of death worldwide, yet much of modern healthcare still focuses on reacting to cardiovascular events after they occur rather than identifying risk earlier and preventing disease progression. Cardio Diagnostics Holdings (NASDAQ: CDIO) is working to help reshape that paradigm through a vision centered on personalized, data-driven cardiovascular care powered by artificial intelligence, epigenetics and genetic insights. Through its proprietary platform and expanding testing capabilities, the company is pursuing a future in which prevention becomes more accessible, scalable and actionable before life-threatening cardiac events occur.

The company’s vision reflects a broader shift taking place across the healthcare industry toward predictive and Precision Medicine. Cardio Diagnostics envisions a healthcare system where every patient receives individualized care informed by their unique molecular insights and where heart disease is no longer the world’s leading killer. Achieving that goal requires a combination of scientific expertise, advanced technology, scalable testing and improved accessibility, all areas the company has identified as foundational pillars of its strategy.

One of the central themes emphasized by Cardio Diagnostics is expert-led innovation. The company operates at the intersection of biotechnology, data science and cardiovascular medicine, bringing together expertise across multiple disciplines to develop its AI-driven diagnostic platform. This multidisciplinary approach is increasingly important as healthcare systems seek to integrate molecular data, including epigenomic and genomic, into clinical decision-making.

Cardio Diagnostics’ focus on innovation is particularly relevant in cardiovascular disease, where earlier identification of risk and disease can significantly influence outcomes. Heart disease remains the leading cause of death in the United States, with more than 800,000 Americans experiencing a heart attack every year, accounting for approximately one in every five deaths. For many, a heart attack is the first sign of coronary heart disease. These statistics underscore the need for more proactive approaches to cardiovascular care, especially tools capable of identifying disease risk before symptoms emerge.

The company’s next-generation technology platform is designed to address this need by using artificial intelligence (“AI”) to integrate multi-omic data, specifically epigenetic markers such as DNA methylation, with genetic information, to provide a more comprehensive view of cardiovascular health. Cardio Diagnostics integrates this information to generate individualized cardiovascular risk assessments from a simple blood sample.

Dynamic biomarkers represent a key component of the company’s strategy. Traditional cardiovascular risk assessments often rely on indicators such as cholesterol levels and blood pressure. While important, these measurements may not fully capture how environmental exposures, lifestyle factors and biological changes influence disease progression over time. Cardio Diagnostics’ platform incorporates epigenetic biomarkers, which can reflect how behaviors, lifestyle and environmental factors alter gene expression.

Research indicates that DNA methylation patterns can reflect environmental exposures and lifestyle influences while also serving as early indicators of disease risk. Because epigenetic markers can change over time, they offer a more dynamic perspective on cardiovascular health than static genetic information alone. Cardio Diagnostics leverages this capability to provide molecular insights intended to support earlier intervention and more personalized care planning.

The company also places significant emphasis on scale and accessibility, recognizing that advanced diagnostics can only create widespread impact if they are practical and broadly available. Blood-based testing is central to this strategy because it allows sophisticated molecular analysis to be delivered through a relatively simple and familiar clinical process. By using blood samples to generate cardiovascular insights, the company aims to make precision diagnostics more compatible with routine healthcare workflows and more accessible across diverse patient populations.

Accessibility has become an increasingly important issue within preventive healthcare. According to the World Health Organization, cardiovascular diseases cause an estimated 17.9 million deaths each year globally, with many cases linked to modifiable risk factors that can potentially be addressed through earlier detection and intervention. Expanding access to scalable preventive tools represents a critical component of reducing long-term disease burden.

Cardio Diagnostics’ vision reflects a broader transformation occurring across medicine as healthcare providers look to move from reactive treatment models toward preventive and precision-based care. By combining expert-led innovation, AI-driven technology, dynamic biomarkers and scalable testing approaches, the company is seeking to redefine how cardiovascular risk and disease are assessed and managed. Its platform is designed not only to provide individualized molecular insights but also to support a healthcare environment where prevention becomes more proactive, data-driven and accessible.

For more information, visit www.CDIO.ai.

NOTE TO INVESTORS: The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO

• GLND secured a five-year drilling agreement with Stampede Drilling for Arctic exploration operations
• The company plans to drill wells targeting multi-billion-barrel hydrocarbon potential in Greenland’s Jameson Land Basin
• These developments position Greenland Energy within one of the North Atlantic’s most promising frontier energy plays

Greenland (NASDAQ: GLND) is accelerating its push into Arctic energy exploration as global demand for new hydrocarbon discoveries continues to grow and traditional resource basins become increasingly mature. With frontier regions returning to focus, Greenland’s Jameson Land Basin is emerging as a potentially significant untapped energy opportunity, and Greenland Energy is positioning itself at the center of that development (ibn.fm/AfUGc).

The company recently announced a five-year drilling agreement with Stampede Drilling Inc. to secure Rig #12, a high-performance drilling rig specifically equipped for Arctic conditions. The agreement supports Greenland Energy’s upcoming drilling campaign in the Jameson Land Basin, where the company plans to drill wells targeting deep hydrocarbon systems across multiple prospective zones.

“Reaching 3,500 meters into the Jameson Land Basin, Greenland Energy will be drilling multi-billion-barrel hydrocarbon potential in one of the North Atlantic’s most promising frontier plays,” the company stated in a recent update. “As work begins on the 2026 drilling program, the target is clear: test the basin’s full hydrocarbon potential and open a new chapter in Arctic energy exploration.”

According to its joint venture partner, 80 Mile PLC, each planned well is expected to reach a minimum depth of 3,500 meters in an effort to delineate the basin’s hydrocarbon potential. The region has been compared geologically to Norway’s prolific Haltenbanken and Barents Sea provinces, both of which have become strategically important energy-producing areas.

Jameson Land spans roughly two million acres in East Greenland and remains largely underexplored despite its significant geological promise. An independent prospective resources report prepared by Sproule ERCE estimated about 13 billion barrels (P10) of gross unrisked recoverable prospective oil resources across the upper levels of the basin, underscoring the scale of the opportunity.

The company is also advancing operational readiness ahead of planned drilling activities in the second part of 2026, subject to regulatory approvals. Greenland Energy is mobilizing heavy equipment to East Greenland and contracted major service providers, including Halliburton and IPT Well Solutions, to support the campaign.

Backing this exploration push, Greenland Energy recently closed a $70 million public offering intended to fund key components of its Jameson Land program, including logistics, procurement, workforce mobilization, and winter-readiness infrastructure. The financing strengthens the company’s ability to execute its exploration strategy as it moves toward drilling operations (ibn.fm/6Fk3r).

Greenland Energy operates within a broader industry trend as supply disruptions, geopolitical instability, and underinvestment in traditional oil basins push energy companies toward frontier exploration regions. Arctic resource development has increasingly gained attention as nations and companies seek long-term supply security and large-scale resource opportunities.

These updates highlight Greenland Energy’s broader mission: to build a publicly traded platform focused on unlocking the hydrocarbon potential of Greenland’s Jameson Land Basin. With drilling preparations advancing, strategic financing secured, and infrastructure partnerships in place, GLND is strategically positioning itself within a high-impact frontier exploration story at a time when global energy markets are increasingly seeking the next major basin opportunity.

For more information, visit the company’s website at www.GreenlandEnergyCo.com.

NOTE TO INVESTORS: The latest news and updates relating to GLND are available in the company’s newsroom at ibn.fm/GLND

Forward-Looking Statements

This communication contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained herein other than statements of present or historical fact, including, without limitation, statements regarding Greenland Energy Company’s (the “Company”) future financial performance, business strategy, operations, financial position, estimated revenues and losses, projected costs, prospects, plans, objectives of management, and expected benefits of the Company’s recent business combination, are forward-looking statements. Forward-looking statements are generally identified by the use of words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “project,”

“forecast,” “potential,” “predict,” or the negative of these terms or similar expressions, although not all forward-looking statements contain such identifying words.

These forward-looking statements are based on management’s current expectations, assumptions and beliefs regarding future events and are based on information currently available to the Company. These statements involve a number of risks and uncertainties, many of which are difficult to predict and are beyond the Company’s control, and actual results may differ materially from those expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially include, among others: (i) Exploration and Geological Risks, including the Company’s status as a development-stage company with no operating history, revenues, or proved reserves; the inherent uncertainty in prospective resource estimates, including that the 13 billion barrel estimate is based on undiscovered accumulations with no certainty of discovery or commercial viability; geological complexity arising from limited seismic data coverage, pervasive igneous intrusions, faulting patterns, and significant Tertiary uplift creating thermal maturity uncertainty; the fact that the basin has never produced a commercial discovery despite decades of study dating back to the 1970s, and a 2008 USGS report stating less than a 10% chance of containing a technically recoverable hydrocarbon accumulation; and high-cost frontier exploration with estimated well costs of $40 million for the first well and $20 million for subsequent wells; (ii) Operational and Environmental Risks, including the challenges of operating in a remote Arctic location with extreme climate, harsh weather, limited daylight, no existing infrastructure, and seasonal access windows for equipment and personnel; drilling hazards such as blowouts, equipment failures, well control events, environmental releases, and accidents inherent in oil and gas operations; reliance on third-party contractors; and climate change scrutiny, as operations in Greenland face increasing opposition from environmental groups and institutional investors due to Arctic drilling concerns; (iii) Regulatory and Political Risks, including the 2021 Greenland drilling moratorium, and while licenses are grandfathered, future regulatory changes could jeopardize operations; geopolitical tensions, including U.S. interest in acquiring Greenland and Greenland’s internal independence movements that could affect operations; permit requirements, as drilling requires Environmental Impact Assessment approval and Field Activities Application approval from Greenlandic authorities; and forfeiture risk, as failure to meet drilling milestones could result in loss of the Company’s right to earn working interests; (iv) Financial and Capital Risks, including significant capital requirements and the need for substantial funding beyond current resources to complete the drilling program; commodity price volatility, as oil, gas, and NGL prices are highly volatile and will heavily influence project viability; a long development timeline during which market conditions may change significantly before potential production, unlike short-cycle shale projects; going concern uncertainty and substantial doubt about the Company’s ability to continue as a going concern without additional financing; and energy transition risk, as global demand for oil may decline due to electric vehicle adoption, renewable energy policies, and changing consumer preferences; and other risks and uncertainties as set forth in the Company’s Prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) under the Securities Act on April 29, 2026, in the section titled “Risk Factors”.

Forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.

• Across the world, natural resource wealth has played a significant role in shaping political outcomes, particularly in smaller or emerging regions seeking greater autonomy.
• Bougainville has long been associated with significant mineral wealth, particularly copper and gold deposits at the Panguna Mine.
• Numa Numa Resources is working to advance mining development in Bougainville in a way that aligns with local priorities and long-term economic goals.

Small islands with large mineral reserves often face a defining question: Can the wealth beneath the ground help fund political and economic independence above it? In Bougainville, Numa Numa Resources is working within this dynamic, positioning itself in a region where resource development and aspirations for self-determination are closely intertwined.

Across the world, natural resource wealth has played a significant role in shaping political outcomes, particularly in smaller or emerging regions seeking greater autonomy. In some cases, resource revenues have helped finance governance structures, infrastructure, and public services that underpin independence. For example, Norway’s sovereign wealth fund, built from oil revenues, has grown into one of the largest in the world, surpassing $1.4 trillion in assets, demonstrating how resource wealth can support long-term national stability and independence. While Norway is neither a small island nor a newly independent state, this fund illustrates how disciplined resource management can create enduring economic strength.

In developing regions, the relationship between natural resources and independence can be more complex. Timor-Leste, which gained independence in 2002, has relied heavily on oil and gas revenues to fund government operations. According to the International Monetary Fund, petroleum revenues have historically accounted for the majority of government income in Timor-Leste, underscoring the critical role resource wealth can play in sustaining a young nation. However, such dependence also highlights the importance of diversification and careful management to avoid volatility.

Bougainville presents a unique case within this broader context. The autonomous region of Papua New Guinea has long been associated with significant mineral wealth, particularly copper and gold deposits at the Panguna Mine. During its operation, Panguna was one of the largest copper mines in the world and contributed substantially to Papua New Guinea’s economy, with the mine accounting for approximately 45% of the country’s export earnings at its peak. Yet disputes over the distribution of these benefits and environmental impacts contributed to a civil conflict that lasted from 1988 to 1998.

Since the Bougainville Peace Agreement in 2001, the region has taken steps toward greater autonomy. In 2019, Bougainville held a nonbinding referendum in which 97.7% of voters supported independence from Papua New Guinea. While the final political outcome remains subject to negotiation with Papua New Guinea, the referendum underscores the strength of local aspirations for self-governance.

Economic viability is a central consideration in any independence process, and resource wealth often plays a key role in that equation. Copper is increasingly viewed as a strategic resource due to its importance in renewable energy systems and electrification. The International Energy Agency projects that demand for copper is expected to rise significantly as the global energy transition accelerates. For regions such as Bougainville, this creates both an opportunity and a challenge: how to responsibly develop resources in a way that supports long-term prosperity.

In addition to traditional resource development, emerging financial concepts have introduced new ways of thinking about how underground wealth might be leveraged. Tokenization, for example, refers to the creation of digital assets backed by real-world resources. While still an evolving concept, the World Economic Forum has noted that asset tokenization could improve liquidity and access to capital by allowing investors to participate in previously illiquid assets. In theory, this could include mineral resources, although practical implementation would require robust governance, transparency and regulatory frameworks. Such approaches remain speculative but can illustrate how innovation could intersect with resource-based economies.

Within this broader landscape, Numa Numa Resources is working to advance mining development in Bougainville in a way that aligns with local priorities and long-term economic goals. Numa Numa emphasizes collaboration with landowners and adherence to Bougainville’s legal and cultural framework, particularly the recognition of customary land rights. This approach reflects lessons from the region’s history, where tensions over land and resource ownership played a central role in past conflict.

By focusing on responsible development, Numa Numa Resources aims to help unlock Bougainville’s mineral potential while supporting economic foundations that could contribute to greater self-sufficiency. The company’s engagement with local stakeholders is intended to ensure that any future mining activities provide tangible benefits to communities, including infrastructure, employment, and revenue generation.

As Bougainville continues to navigate its political future, the relationship between resource wealth and independence remains a central theme. The region’s experience highlights both the promise and the complexity of relying on natural resources as a pathway to self-determination. Success will depend not only on the presence of valuable minerals but also on how those resources are managed, shared, and integrated into a broader economic strategy.

Numa Numa Resources is operating within this evolving environment, where economic development, governance and community engagement are closely linked. While the path forward for Bougainville is still being defined, the interplay between resource wealth and independence will likely continue to shape the region’s trajectory for years to come.

For more information, visit www.NumaNumaResources.com.

NOTE TO INVESTORS: The latest news and updates relating to Numa Numa are available in the company’s newsroom at https://ibn.fm/NUMA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

• BOXABL has appointed technology executive Shan Palaniappan as chief technology officer as it expands automation, software and AI capabilities across operations.
• The company is pursuing a proposed merger with FG Merger II Corp. (NASDAQ: FGMC), with the combined company expected to trade under the ticker Nasdaq: BXBL.
• BOXABL has already produced more than 800 housing units from its Las Vegas manufacturing facility and is targeting multiple residential and commercial market segments.
• The company’s modular system is designed to support scalable deployment for single-family homes, multifamily housing, workforce accommodations, and hospitality projects.
• Management sees long-term opportunity in combining home production with recurring service revenues tied to financing, insurance, and maintenance.

BOXABL, an innovative technology construction company on a mission to solve the global affordable housing crisis, is attempting to apply manufacturing principles more commonly associated with the automotive and consumer electronics industries to one of the least standardized sectors of the American economy: residential construction.

Headquartered in Las Vegas, Nevada, the company is building a factory-based housing platform centered on modular, foldable residential units that can be transported on standard trailers and quickly assembled on-site. BOXABL’s broader objective is to shift homebuilding away from fragmented field construction toward a more standardized production model.

The company is currently advancing through an S-4 registration process tied to its previously announced merger agreement with FG Merger II Corp., a special purpose acquisition company trading on Nasdaq under the ticker FGMC. Once the transaction is completed, the combined entity is expected to trade as BXBL on Nasdaq. The transaction represents a test of whether factory-built housing can move beyond niche modular applications and scale into a larger share of mainstream residential construction.

BOXABL’s strategy is based upon flexibility. BOXABL says its modular units are designed to stack and connect, allowing them to be adapted for townhomes, apartment-style developments, workforce housing, hospitality projects, and larger single-family residences.

The company’s basic flagship product is the Casita, a 361-square-foot modular studio-style home designed to arrive largely finished from the factory. Units include kitchens, bathrooms, electrical systems and plumbing infrastructure before transport. Once delivered, the structures unfold on-site into completed living spaces.

However, the company has since expanded the platform into additional configurations, including one-bedroom and two-bedroom layouts, while also developing the Baby Box, a smaller unit built to RV standards for less complex installations.

The company operates from a roughly 400,000-square-foot manufacturing facility in Las Vegas, where management says more than 800 homes have been produced to date. Unlike conventional homebuilders that rely heavily on subcontractors and project-specific workflows, BOXABL is attempting to standardize production inside a controlled manufacturing environment, with technology and design that differentiates it from previous manufactured home operations. The company believes this will improve construction speed, reduce defects, and lower overall costs through repeatable processes and automation.

That emphasis on technology was reinforced in March when BOXABL announced the appointment of Shanmugam “Shan” Palaniappan as chief technology officer. Palaniappan previously held engineering and technology leadership positions at companies including Salesforce, Demandware, DataRobot and Sagent. According to BOXABL, his mandate includes expanding software infrastructure, factory automation and AI-driven operational systems.

Management says the company is working toward integrating real-time analytics into areas such as sales forecasting, production planning, land feasibility analysis and supply-chain management. The goal is to improve throughput while reducing inefficiencies across the manufacturing process.

The company’s strategy reflects a broader trend across industrial sectors where software increasingly shapes operational execution. In housing construction, where productivity growth has lagged other industries for decades, proponents of factory-built systems argue that automation and standardization may help offset labor constraints and cost inflation.

BOXABL is entering a market with substantial demand drivers. The company estimates the broader U.S. housing market represents roughly $2.2 trillion in addressable demand, citing a combination of housing shortages and ongoing affordability challenges. Industry estimates referenced by the company point to a national housing shortfall of more than four million homes.

Management also identifies regulatory and permitting complexity as structural contributors to rising construction costs. By standardizing portions of the building process within a factory setting, BOXABL believes it can reduce variability and improve cost predictability.

Within that broader market, the company is initially focused on modular and manufactured housing segments. BOXABL estimates its immediate obtainable market at approximately $1 billion annually based on projected single-factory production capacity and average unit pricing.

The company’s business model extends beyond unit sales alone. Management has discussed developing ancillary service revenue opportunities tied to financing, insurance, maintenance and installation services. That approach could provide higher-margin recurring revenue streams alongside home production.

For more information, visit the company’s website at www.Boxabl.com.

• Research supports the urgent need for more effective tools to identify the risk of cardiovascular disease earlier and guide personalized intervention strategies.
• Cardio Diagnostics’ solutions reflect a strategy aimed at addressing cardiovascular disease across multiple stages of care.
• This emphasis on prevention aligns with growing recognition that earlier intervention can significantly improve long-term outcomes.

Most people are aware that cardiovascular disease (“CVD”) is the leading cause of death in the United States; what they might not know is that an estimated 80% of those cases are considered preventable through earlier detection and proactive management of key risk factors. This highlights the urgent need for more effective tools that can identify risk earlier and guide personalized intervention strategies. Cardio Diagnostics Holdings (NASDAQ: CDIO) is rising to the challenge by developing a suite of clinical, population health and biopharma solutions designed to leverage artificial intelligence (“AI”), epigenetics and genetics to improve cardiovascular disease prevention, detection and management.

The company’s platform is built around the integration of genetic and epigenetic biomarkers with AI-driven analytics to provide personalized cardiovascular insights from blood-based testing. Cardio Diagnostics currently offers two clinical solutions, Epi+Gen CHD(TM) and PrecisionCHD(TM), as well as a population health and biopharma offerings, HeartRisk(TM) and CardioInnovate360(TM), respectively. Collectively, these solutions reflect a strategy aimed at addressing cardiovascular disease across multiple stages of care, from early detection and prevention to therapeutic development and population-level risk management.

One of the company’s flagship clinical offerings, Epi+Gen CHD is designed to assess an individual’s three-year risk of having a coronary heart disease event, including a heart attack, by analyzing both epigenetic and genetic biomarkers. Unlike traditional cardiovascular assessments that often rely heavily on demographic data or standard laboratory measurements, Epi+Gen CHD seeks to capture a more comprehensive molecular profile. 

CVD is largely driven by lifestyle and environment, not genetics. Therefore, the inclusion of epigenetic markers such as DNA methylation patterns is particularly significant because these biomarkers can reflect the influence of lifestyle, environmental exposures and disease processes on gene expression over time. By integrating these biomarkers with AI-powered analysis, Cardio Diagnostics is working to improve the precision and personalization of cardiovascular assessment.

The company’s second clinical solution, PrecisionCHD, is designed to aid in the diagnosis of coronary heart disease when there is clinical suspicion of disease. This preventive orientation reflects a broader shift within healthcare toward identifying disease earlier and intervening before disease progression leads to severe outcomes such as heart attacks. PrecisionCHD is intended to support physicians and patients in making more informed preventive care decisions based on personalized molecular insights.

This emphasis on prevention aligns with growing recognition that earlier intervention can significantly improve long-term outcomes. The Centers for Disease Control and Prevention notes that controlling major risk factors such as high blood pressure, high cholesterol, diabetes and smoking can substantially reduce the likelihood of cardiovascular events. However, many individuals remain unaware of their underlying risk until symptoms appear. Clinical solutions such as Epi+Gen CHD and PrecisionCHD are designed to help close that gap by identifying predisposition earlier in the disease continuum.

Beyond individual clinical diagnostics, Cardio Diagnostics is also targeting broader population health applications through HeartRisk. This solution is designed to support employers, health systems and population health organizations by helping identify cardiovascular risk across larger groups of individuals. Population health initiatives have become increasingly important as healthcare systems seek to reduce long-term costs and improve preventive care outcomes at scale.

The economic implications of cardiovascular disease further reinforce the value of such approaches. The CDC reports that heart disease and stroke together cost the United States hundreds of billions of dollars annually in healthcare expenses and lost productivity. Earlier risk identification and targeted preventive interventions could help reduce some of this burden by minimizing avoidable hospitalizations and advanced disease complications.

CardioInnovate360 expands the Cardio Diagnostics’ reach into the biopharma and research sectors. According to CDIO, this solution is intended to support pharmaceutical and biotechnology companies through biomarker discovery, drug development and Precision Medicine applications. The integration of AI with multi-omic biomarker analysis has the potential to enhance understanding of disease mechanisms, improve patient stratification and support more targeted therapeutic development.

Artificial intelligence plays a central role across all of the company’s offerings. AI systems are capable of analyzing large and complex biological datasets to identify patterns and relationships that may not be apparent through traditional analytical methods. Cardio Diagnostics’ solutions are built around this principle, using machine learning to help transform molecular data into clinically actionable information.

The company’s emphasis on blood-based testing and scalable analytics also supports broader accessibility. Blood tests are already deeply integrated into routine healthcare workflows, making them practical tools for widespread testing and monitoring. By combining familiar clinical processes with advanced AI-driven analysis, Cardio Diagnostics is seeking to bridge the gap between cutting-edge molecular science and real-world clinical adoption.

As cardiovascular disease continues to impact millions of people worldwide, the need for more personalized and preventive approaches remains substantial. Through Epi+Gen CHD, PrecisionCHD, HeartRisk and CardioInnovate360, Cardio Diagnostics is building a portfolio of solutions intended to address cardiovascular disease across clinical care, population health and therapeutic innovation. By leveraging AI, genetics and epigenetics, the company is positioning itself within the growing movement toward precision cardiovascular medicine and earlier, more proactive disease management.

For more information, visit www.CDIO.ai.

NOTE TO INVESTORS: The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO

• The company’s proprietary FASForm(TM) platform advancing new approach to coal.
• Frontieras processes coal into multiple commercially valuable outputs, tied to markets estimated at more than $2 trillion.
• Core thesis is that coal’s largest missed opportunity lies not in power generation alone but in its unrealized value as a diversified industrial resource.

Global demand for energy is accelerating at a historic pace as artificial intelligence (“AI”), advanced manufacturing and industrial expansion place increasing pressure on existing power systems. Governments and industries are exploring nearly every available energy source to meet that demand, yet one of the world’s most abundant and energy-dense resources remains widely overlooked and underutilized.

Frontieras North America is advancing a new approach to coal through its proprietary FASForm(TM) platform, which converts coal into fuels, hydrogen and industrial materials, positioning the resource as a multi-output industrial feedstock capable of supporting modern energy and manufacturing markets.

Coal has served as a foundational global energy source since the Industrial Revolution and remains the world’s largest source of electricity generation more than 200 years later, according to the International Energy Agency. Coal supply is ample, with global proven recoverable coal reserves estimated at approximately 1.16 trillion short tons, enough to support production for more than a century at current consumption rates. Few energy resources match coal’s combination of scale, availability and existing infrastructure.

Yet despite those fundamentals, the coal industry has spent years under pressure from shifting energy policies, rising operational costs and the rapid expansion of alternative energy investment. Coal-fired power plants across parts of the United States and Europe have been retired or scheduled for closure, while investment in new coal technologies slowed substantially during the global transition toward renewable energy systems. Rising oil prices and supply volatility have further complicated global energy markets, exposing vulnerabilities in fuel supply chains and increasing pressure on governments and industries to secure stable domestic energy resources.

Within that environment, Frontieras North America is advancing a fundamentally different approach to coal utilization. Rather than treating coal as a single-use combustion fuel, the company positions it as a multi-output industrial resource capable of producing fuels, hydrogen, industrial carbon products and chemical feedstocks simultaneously. Matthew McKean, Frontieras cofounder and CEO, describes the company’s FASForm Solid Carbon Fractionation technology as “a patented, zero-waste process that takes coal and disassembles it at the molecular level into multiple higher-value products: ultra-low sulfur diesel, naphtha, purified solid carbon fuel, hydrogen, ammonium sulfate fertilizer, and industrial chemicals.

“No combustion. No emissions from the process itself,” McKean continues. “Six product streams from a single feedstock, produced entirely from American resources on American soil. This is what it looks like when you stop apologizing for coal and start unlocking what coal actually is: the most energy-dense, abundant, accessible hydrocarbon resource on the planet, sitting under our feet, waiting to be fractionated into the fuels, fertilizers and chemicals the world is right now scrambling to secure.”

Conventional coal use extracts only a portion of the resource’s broader value by burning it solely for heat or electricity generation. Frontieras instead fractionates coal into multiple commercially valuable outputs. The scale of the markets tied to those products is substantial, estimated to be more than $2 trillion. Diesel remains one of the world’s foundational transportation and industrial fuels, powering freight logistics, construction equipment and heavy machinery globally. Jet fuel demand continues to expand alongside commercial aviation activity.

Hydrogen plays a critical role in refining, industrial manufacturing and chemicals production, while naphtha serves as a core petrochemical feedstock used in plastics, synthetic fibers and industrial materials manufacturing. In addition, Frontieras’s FASCarbon(TM) further expands the company’s reach into industrial materials sectors. Frontieras describes the product as a virtually sulfur-free technical carbon that can serve as a replacement carbon source in steel manufacturing and industrial thermal applications, burning hotter and cleaner than conventional petroleum coke while supporting steel-coke and industrial heating markets that rely on carbon-intensive feedstocks. The company also integrates fertilizer and industrial chemical production into its process. This multi-output structure allows one facility to participate across transportation, industrial manufacturing, agriculture and materials markets simultaneously.

Frontieras’s thesis is that coal’s largest missed opportunity lies not in power generation alone but in its unrealized value as a diversified industrial resource. Coal contains hydrocarbons, carbon compounds and chemical elements that support fuels, manufacturing inputs, fertilizer production and industrial materials. The company’s modern processing technology unlocks those components at commercial scale while operating as a closed-loop system that captures and repurposes process byproducts.

As energy demand continues rising alongside industrial expansion, AI infrastructure growth and manufacturing activity, systems capable of delivering reliable fuel and material outputs at scale are becoming increasingly important. Frontieras North America is positioning itself within that landscape by redefining how coal is processed and utilized. Through FASForm, the company is establishing a model in which coal operates not as a declining commodity but as a high-value industrial feedstock capable of supporting multiple trillion-dollar global markets through a single integrated process.

For more information about Frontieras, visit the company’s website at www.Frontieras.com.

NOTE TO INVESTORS: The latest news and updates relating to Frontieras are available in the company’s newsroom at https://ibn.fm/Frontieras

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

• GPS jamming is quickly turning into a common weapon in war, as it disrupts and interrupts many of the crucial aspects of modern wars, such as communication, navigation, and precision targeting.
• However, GPS jamming isn’t only felt in war, as the effects can expand beyond the battlefield and impact civilians in frustrating and potentially dangerous ways.
• Companies like SPARC AI Inc. are developing GPS-free navigation and target acquisition software that continue to operate even in GPS-denied areas.

Navigation interference has emerged as one of the most common and disruptive tools in modern electronic warfare. Once considered a niche capability, it is now routinely deployed in conflicts around the world.

GPS jamming is a form of electronic warfare that blocks or overwhelms GPS satellite signals, disrupting navigation, precision targeting, drone operations, and communications. It works by broadcasting powerful radio noise on the same frequencies used by GPS satellites, effectively drowning out the much weaker legitimate signals.

Technology’s growing popularity stems from GPS’s inherent vulnerabilities. GPS signals originate from satellites more than 20,000 km (12,400 miles) away in orbit, arriving at Earth as extremely weak signals. This makes it relatively easy to overpower with even modest jamming equipment. Many civilian GPS signals are also unencrypted and openly accessible, further increasing their susceptibility.

While GPS jamming is primarily used to disable enemy drones, missiles, and navigation systems, its effects frequently spill beyond the battlefield. Civilian aircraft, commercial shipping, and everyday navigation systems are often collateral victims. In high-intensity jamming zones, hundreds of commercial flights can be affected daily, with roughly 900 flights reportedly impacted each day by GPS interference in some regions.

The consequences for civilians and commerce are significant: delayed or rerouted flights, slowed maritime traffic, increased risk of accidents, and cargo misrouted due to faulty positioning data.

Countering the Threat

In response to this growing challenge, companies are developing robust alternatives to GPS-dependent systems. One notable example is SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF), which is building GPS-free target acquisition and autonomous navigation technology.

SPARC AI’s solution combines advanced mathematics, AI modeling, and edge computing to deliver real-time tracking, detection, and behavioral insights without relying on GPS, radar, lidar, or other heavy sensors. Designed specifically for Denied, Degraded, Intermittent, and Limited (“DDIL”) environments, the system operates with zero detectable emissions and requires no additional hardware. It leverages existing drone cameras and sensors to provide accurate geospatial intelligence, distance calculation, AI-driven targeting, and terrain integration.

By offering a software-only solution that functions effectively even when traditional navigation systems fail, SPARC AI aims to enhance situational awareness and operational safety for defense, commercial, and rescue organizations in contested environments.

For more information, visit the company’s website at https://sparcai.co.

NOTE TO INVESTORS: The latest news and updates relating to SPAIF are available in the company’s newsroom at https://ibn.fm/SPAIF

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

• During a recent TechMediaWire Podcast appearance, Justin Hanka outlined MindBio Therapeutics’ progress in developing advanced AI-driven voice analysis technology for drug and alcohol intoxication detection.
• MindBio Therapeutics Corp. says its prediction models are trained using more than 50 million data points collected through years of clinical and behavioral research.
• The company’s initial commercial strategy focuses on workplace safety sectors including mining, aviation, and construction, where impairment-related incidents carry significant operational and regulatory risks.
• Hanka said during the interview that the company’s voice-analysis platform can detect not only alcohol intoxication but also drugs affecting the central nervous system, including cannabis, cocaine, opioids, and psychedelics.
• Management expects live workplace testing deployments to begin later in the second quarter of 2026 as the company transitions from development toward commercial implementation.
• MindBio views its technology as part of a broader AI-driven diagnostics technology capable of supporting future health and wellness applications beyond intoxication monitoring.

MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF), a biotechnology company commercializing AI-driven voice technology for drug and alcohol intoxication detection, used a recent appearance on the TechMediaWire Podcast to outline how the company plans to commercialize its technology, starting with testing plans as of Q2 this year (https://ibn.fm/HLMKz). During the discussion with podcast host Stuart Smith, MindBio Founder and Chief Executive Officer Justin Hanka described the company’s work using speech analytics and machine learning to identify physiological indicators associated with intoxication through non-invasive voice analysis (https://ibn.fm/BUKfp).

According to Hanka, MindBio has spent several years conducting drug and alcohol research while collecting extensive speech and voice datasets through clinical studies and related programs. As AI and machine-learning systems have improved, the company believes it has developed models capable of identifying intoxication by analyzing vocal patterns, cadence and speech characteristics. The company says its prediction models are built using more than 50 million data points and are designed to evaluate changes in speech linked to alcohol and drug use.

A central theme of the podcast discussion was how MindBio’s technology differs from traditional intoxication testing methods. Hanka contrasted the company’s voice-based approach with conventional testing systems that rely on biological samples such as breath, saliva, urine, blood or hair analysis.

MindBio’s platform instead seeks to provide a scalable, non-invasive screening method that can operate in workplace and public environments without interrupting operations or requiring physical sample collection.

During the interview, Hanka emphasized that the technology’s commercial potential extends well beyond alcohol detection. He said the company’s AI models can now identify indicators associated with multiple categories of drugs that affect the central nervous system. Those categories include cannabis, cocaine, opioids and psychedelic substances such as psilocybin and lysergic acid diethylamide, commonly known as LSD.

Management characterized those developments as an important expansion of the company’s capabilities because large-scale detection of non-alcohol intoxication remains operationally difficult in many workplace environments.

The company’s initial commercial focus is workplace health and safety, particularly in sectors with elevated operational risk and mandatory testing requirements. During the podcast discussion, Hanka pointed specifically to the mining industry as an early entry market. He described mining operations as environments where regulators, operators and labor organizations all have incentives to reduce impairment-related incidents because workplace shutdowns can create substantial financial consequences.

According to Hanka, many mining operations currently rely on random testing protocols because continuously screening thousands of workers entering industrial sites is difficult using conventional methods. MindBio believes its voice-analysis platform could substantially increase testing frequency at entry gates or throughout operational sites.

The company also discussed opportunities in aviation, construction, and law enforcement environments, where scalable intoxication screening can improve safety monitoring.

Another topic raised during the interview was the adaptability of the company’s technology across languages and regions. Hanka said MindBio has trained its models using multilingual voice samples and varying accents, including English- and Spanish-language datasets relevant to South American markets. The company has already begun discussions tied to potential mining-sector deployments in Chile and other South American jurisdictions.

MindBio is currently building enterprise deployment systems that combine proprietary software with Edge-AI hardware kiosks capable of rapidly analyzing speech inputs. Management says intoxication assessments can occur in less than three seconds.

Hanka also used the podcast interview to outline several operational objectives for 2026. He said the company has recently completed key funding milestones, raised approximately $2.5 million for development activities and continued refining its prediction models and deployment systems.

Most importantly, management expects the company’s technology to enter live workplace testing later in the second quarter of 2026. Hanka described that rollout as a significant milestone because it represents the transition from research and engineering toward practical commercial implementation.

The interview also highlighted the company’s broader ambitions beyond workplace intoxication detection. Hanka suggested that MindBio increasingly sees itself evolving into a broader diagnostics business centered around AI-driven voice analytics. The underlying concept is that speech may function as a biomarker for a range of physiological and neurological conditions because vocal characteristics can reflect changes occurring inside the body.

For more information, visit the company’s website at www.MindBioTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF

• BluSky AI’s business plan includes the rapid deployment of SkyMod data centers intended to address rising demand for high-performance AI infrastructure.
• The company’s strategy reflects a broader mission to expand access to AI computing through flexible, efficient, and fast-to-deploy modular systems.

The global demand for compute, energy, specialized chips, and data center infrastructure continues to grow at a pace that challenges traditional development timelines. What was once a steady progression in hardware and software has evolved into a race to maintain capacity, where organizations increasingly recognize that physical infrastructure is a critical limiting factor.

Industry commentary has underscored this shift. In Rewired, a recent publication by McKinsey & Company, the authors note that companies able to innovate rapidly with AI may be better positioned to compete. As AI adoption expands, organizations that lack access to scalable compute resources may face operational constraints.

Against this backdrop, BluSky AI (OTC: BSAI) is advancing a modular, deployment-first approach designed to align infrastructure availability with the growing demand for high-performance computing. The company’s strategy centers on its Distributed Neocloud model, which is being developed to support machine learning workloads and inference computing without the limitations associated with legacy cloud environments.

At the core of this approach is BluSky AI’s proprietary SkyMod architecture—next-generation modular data centers engineered as scalable “AI factories.” These units are designed for rapid deployment, with the goal of reducing the time required to bring new AI infrastructure online. Traditional data center projects can take several years to complete, depending on permitting, construction, and power availability. BluSky AI’s management believes that modular systems may help narrow this timeline by enabling capacity to be added incrementally as demand evolves.

The company’s business plan includes deploying SkyMod data centers purpose-built for artificial intelligence workloads. This reflects a broader shift in how infrastructure is conceptualized, moving from static, capital-intensive builds to modular systems that can scale with technological needs. BluSky AI’s Distributed Neocloud model is being designed specifically for inference computing, supported by a network of geographically distributed locations across the United States. Management believes this approach may help address the growing need for low-latency, millisecond-level performance as inference workloads become a larger share of AI activity.

Industry leaders have also highlighted the importance of inference. At NVIDIA’s GTC conference, CEO Jensen Huang described the industry as entering an “inference era,” noting that models increasingly operate in real time to reason, act, and interact. While BluSky AI does not provide forecasts for the broader market, the company recognizes that inference-driven applications may require infrastructure positioned closer to end users.

BluSky AI’s platform is being developed to serve a broad range of customers, including early-stage innovators, enterprises, and research institutions. By lowering barriers to accessing advanced AI infrastructure, the company aims to support organizations pursuing machine learning initiatives and inference-based applications while maintaining a focus on performance and efficiency.

The company’s modular architecture also introduces an economic model designed to support incremental scalability. Customers may expand capacity as needed, potentially reducing upfront capital requirements while enabling recurring utilization. Management believes this structure aligns BluSky AI’s long-term growth opportunities with the continued expansion of AI adoption.

As the global AI ecosystem evolves, infrastructure providers capable of delivering efficiency, speed, and adaptability may play an increasingly important role. BluSky AI’s SkyMod-driven Distributed Neocloud model represents a differentiated approach within the broader cloud and data center landscape—one focused on the specific requirements of AI workloads and the emerging needs of inference computing.

For more information, visit BluSkyAIDataCenters.com.

NOTE TO INVESTORS: The latest news and updates relating to BSAI are available in the company’s newsroom at https://ibn.fm/BSAI

• American Fusion(TM), developer of next-generation fusion energy technologies, has completed the structural frame for its 5MW Texatron(TM) pre-production system, marking a transition toward integrated assembly and controlled testing.
• The company is developing modular fusion energy systems through its subsidiary Kepler Fusion Technologies, with a focus on scalable infrastructure-grade applications.
• American Fusion(TM) says the 5MW unit will support diagnostics, instrumentation validation and system integration ahead of broader performance evaluation activities.
• The company is simultaneously advancing larger 10 MW, 20MW, 50MW and 100MW Texatron(TM) designs intended to support future commercial deployment scenarios.
• American Fusion(TM) has initiated regulatory review processes in Texas and is raising up to $5 million to support continued development and testing activities.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, is entering a new stage in its development efforts as the company moves beyond early prototype work and toward integrated testing of its Texatron(TM) fusion platform. The Texas-based company recently announced completion of the structural frame for its 5-megawatt Texatron(TM) pre-production unit, a milestone that management says advances the project toward full system assembly and controlled testing readiness (https://ibn.fm/SiutU).

American Fusion(TM) is focused on developing fusion energy systems through its wholly owned subsidiary, Kepler Fusion Technologies. Following its merger with Kepler, the company adopted the American Fusion(TM) name and repositioned itself around long-term commercialization of modular fusion energy systems.

Fusion energy remains one of the most closely watched areas within advanced energy technology. The concept seeks to replicate the same nuclear fusion processes that power the sun, potentially generating large amounts of electricity with lower long-term fuel requirements and reduced carbon emissions compared with fossil fuels. However, despite decades of research across the public and private sectors, commercial fusion power remains in development globally.

American Fusion(TM) is pursuing a proprietary approach it describes as a pulsed torsatron system using deuterium-helium-3 fuel concepts. The company has stated that it has achieved stable plasma formation during earlier development work, though the technology remains in an engineering and testing phase.

The newly completed structural frame represents the physical foundation for the company’s 5MW pre-production system. According to management, the platform will support integration of diagnostics, wiring infrastructure, shielding systems, instrumentation and operational controls necessary for future testing. The unit is currently undergoing additional integration work in Odessa, Texas before shipment to the company’s Fort Worth facility, where controlled testing activities are expected to occur following regulatory review and site preparation.

American Fusion(TM) said it has submitted an application to the Texas Department of State Health Services related to planned testing operations and facility infrastructure. Initial work is expected to focus on assembly, diagnostics integration, instrumentation calibration and safety validation before broader operational testing proceeds.

Chief Technology Officer Dr. John Brandenburg said the transition from prototype development to integrated system assembly represents an engineering progression toward controlled validation of the Texatron(TM) architecture.

“Completion of the pre-production frame is an important engineering milestone because it moves the Texatron platform from prototype development toward integrated system assembly and controlled testing. Our focus now is disciplined integration, instrumentation, regulatory compliance, and data collection so that system performance can ultimately be evaluated in a controlled environment,” he said.

American Fusion(TM) says it has already designed and constructed nine earlier Texatron(TM) prototypes. The company views the 5MW system as its first pre-production platform intended to bridge the gap between laboratory-scale experimentation and infrastructure-oriented deployment models.

Management is also developing a larger 100MW Texatron(TM) configuration, which it sees as the basis for eventual commercial deployment. According to CEO Brent Nelson, the company’s modular strategy is intended to allow generation capacity to scale incrementally using standardized reactor units. In practical terms, multiple 100MW units could theoretically be combined into utility-scale generation projects if the technology ultimately proves commercially viable.

Alongside technical development, the company is also seeking additional funding. American Fusion(TM) recently engaged Revere Securities LLC as a non-exclusive finder in connection with a proposed capital raise of up to $5 million. According to the company, proceeds would support system integration, diagnostics procurement, testing activities and working capital requirements. 

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to AMFN are available in the company’s newsroom at https://ibn.fm/AMFN